Stocks In Focus For Tuesday 12/01/15 – GTHP BIEI TPIV

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you enjoyed some extra time off through the Thanksgiving holiday here in the U.S. and found time to spend with loved ones. Tomorrow marks the first day of the final trading month of the year, and as we head into December we expect an abundance of green instead of the much less pleasant color (red).

GTHP (Guided Therapeutics, Inc.) had it’s biggest day of the year to finish November on an extremely high note, closing up more than 63% with nearly 8.7 million shares exchanging hands, and ended the day not far off it’s session high of .042 at .04 per share. Shares hit a 52 week low of .0141 just a couple weeks ago, but have been trending higher since, after trading at more than .20 to start the year. GTHP has a long room to bounce, but has been under a lot of pressure and has been trading with a lot of volatility; watch for a break past .042 to potentially fuel more momentum in the stock which could warrant a trade.

BIEI (Premier Biomedical, Inc.) continues to hold higher from our initial watch list alert below .01, maintaining key support at .015, and closed above .02 again today showing impressive strength. The main problem from our perspective has been a toxic market maker, VFIN, which has held BIEI back from sustaining larger moves. If this market maker takes a leave of absence or doesn’t take the stock below .015 support, it could keep moving higher and remains on our watch list.

TPIV (TapImmune, Inc.) remains in focus through the end of the year as the company looks to receive Orphan Drug Designation (ODD) from the FDA and FDA Fast Track designation for their breast cancer vaccines, which we have outlined multiple times in several blog posts. We remain bullish until the company gives us a fundamental reason not to be.

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!


The Penny Stock Experts Team At

Please read our legal Disclaimer below:

We continue trade up to 100,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time. We have no position at this time.

This disclaimer is to be read in its entirety, and fully understood before using or joining the email list. reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Your continued use of the website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit does not accept free-trading shares as a form of payment.